Par Drugs and Chemicals Limited Receives Confirmatory Order from SEBI Regarding Slump Sale
Par Drugs and Chemicals Limited announced on March 26, 2026, that it received a Confirmatory Order from the Securities and Exchange Board of India (SEBI) concerning a slump sale. The order, issued by Mr. Kamlesh Chandra Varshney, Whole Time Member of SEBI, confirms directions initially outlined in an Ex-Parte Interim Order dated September 15, 2025.According to the Confirmatory Order, the observations are tentative pending a detailed investigation. The investigation will be conducted independently of the interim and confirmatory orders. SEBI reserves the right to take further action based on the investigation's outcome.
The company received the Confirmatory Order via email on Wednesday, March 25, 2026, at 04:03 PM. The full order can be accessed on the SEBI official website or via a QR code. The order has no quantifiable monetary impact on the company’s financial, operational, or other activities as of the date of the announcement.
| Name of the authority | Mr. Kamlesh Chandra Varshney Whole Time Member Securities And Exchange Board Of India (SEBI) |
|---|---|
| Nature of action | Confirmation of directions issued vide Ex-Parte Interim Order No. WTM/KV/CFID/CFID-SEC4/31660/2025-26 dated September 15, 2025. |
| Date of receipt | Wednesday, March 25, 2026 at 04:03 PM |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.